A detailed history of Northern Trust Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 433,820 shares of CRL stock, worth $84.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
433,820
Previous 457,897 5.26%
Holding current value
$84.9 Million
Previous $94.6 Million 9.66%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $4.53 Million - $5.91 Million
-24,077 Reduced 5.26%
433,820 $85.5 Million
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $279,452 - $363,860
-1,354 Reduced 0.29%
457,897 $94.6 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $4.3 Million - $5.78 Million
-21,135 Reduced 4.4%
459,251 $124 Million
Q4 2023

Feb 13, 2024

SELL
$164.52 - $238.84 $2.81 Million - $4.08 Million
-17,081 Reduced 3.43%
480,386 $114 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $4.71 Million - $5.28 Million
24,249 Added 5.12%
497,467 $97.5 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $3.27 Million - $3.74 Million
-17,809 Reduced 3.63%
473,218 $99.5 Million
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $1.01 Million - $1.37 Million
-5,272 Reduced 1.06%
491,027 $99.1 Million
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $339,817 - $431,120
1,724 Added 0.35%
496,299 $108 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $1 Million - $1.37 Million
-5,484 Reduced 1.1%
494,575 $97.3 Million
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $1.18 Million - $1.75 Million
-5,786 Reduced 1.14%
500,059 $107 Million
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $2.98 Million - $4.22 Million
-11,644 Reduced 2.25%
505,845 $144 Million
Q4 2021

Feb 08, 2022

SELL
$351.38 - $448.68 $3.46 Million - $4.42 Million
-9,860 Reduced 1.87%
517,489 $195 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $5.36 Million - $6.59 Million
14,387 Added 2.8%
527,349 $218 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $22.3 Million - $28.1 Million
75,720 Added 17.32%
512,962 $190 Million
Q1 2021

May 12, 2021

BUY
$249.67 - $299.48 $10.1 Million - $12.1 Million
40,500 Added 10.21%
437,242 $127 Million
Q4 2020

Feb 11, 2021

SELL
$222.0 - $252.62 $2.07 Million - $2.35 Million
-9,318 Reduced 2.29%
396,742 $99.1 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $3.17 Million - $4.09 Million
-18,041 Reduced 4.25%
406,060 $92 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $1.48 Million - $2.36 Million
12,444 Added 3.02%
424,101 $73.9 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $1.8 Million - $3.25 Million
18,226 Added 4.63%
411,657 $52 Million
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $1.06 Million - $1.28 Million
8,372 Added 2.17%
393,431 $60.1 Million
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $242,260 - $278,288
-1,937 Reduced 0.5%
385,059 $51 Million
Q2 2019

Aug 13, 2019

BUY
$123.4 - $148.55 $432,393 - $520,519
3,504 Added 0.91%
386,996 $54.9 Million
Q1 2019

May 13, 2019

BUY
$104.82 - $146.73 $1.11 Million - $1.55 Million
10,570 Added 2.83%
383,492 $55.7 Million
Q4 2018

Feb 12, 2019

BUY
$105.09 - $137.23 $335,552 - $438,175
3,193 Added 0.86%
372,922 $42.2 Million
Q3 2018

Nov 14, 2018

SELL
$112.11 - $134.54 $1.2 Million - $1.44 Million
-10,669 Reduced 2.8%
369,729 $49.7 Million
Q2 2018

Sep 18, 2018

SELL
$102.37 - $117.25 $298,510 - $341,901
-2,916 Reduced 0.76%
380,398 $42.7 Million
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $2.94 Million - $3.37 Million
-28,733 Reduced 6.97%
383,314 $43 Million
Q1 2018

May 09, 2018

SELL
$98.19 - $115.2 $1.14 Million - $1.34 Million
-11,600 Reduced 2.74%
412,047 $44 Million
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $266,340 - $313,174
-2,652 Reduced 0.62%
423,647 $46.4 Million
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $41.2 Million - $46.6 Million
426,299
426,299 $46.1 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.